|
2002 Conference Publication Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidineTwigg, SM, Cao, Z, Burns, WC, Brammar, G, Forbes, JM and Cooper, ME (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. AMER DIABETES ASSOC. |
|
2002 Journal Article Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuriaForbes, Josephine M., Bonnet, Fabrice, Russo, Leileata M., Burns, Wendy C., Cao, Zemin, Candido, Riccardo, Kawachi, Hiroshi, Allen, Terri J., Cooper, Mark E., Jerums, George and Osicka, Tanya M. (2002). Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. Journal of Hypertension, 20 (5), 985-992. doi: 10.1097/00004872-200205000-00034 |
|
2001 Journal Article Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Oldfield, MD, Bach, LA, Forbes, JM, Nikolic-Paterson, D, McRobert, A, Thallas, V, Atkins, RC, Osicka, T, Jerums, G and Cooper, ME (2001). Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). Journal of Clinical Investigation, 108 (12), 1853-1863. doi: 10.1172/jci11951 |
|
2001 Journal Article Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney functionForbes, Josephine Maree, Hewitson, Timothy David, Becker, Gavin James and Jones, Colin Lindsay (2001). Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney International, 59 (4), 1333-1341. doi: 10.1046/j.1523-1755.2001.0590041333.x |
|
2001 Journal Article Renoprotective effects of a novel inhibitor of advanced glycationForbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G. and Cooper, M. E. (2001). Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia, 44 (1), 108-114. doi: 10.1007/s001250051587 |
|
2001 Journal Article Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failureForbes, JM, Jandeleit-Dahm, K, Allen, TJ, Hewitson, TD, Becker, GJ and Jones, CL (2001). Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Experimental Nephrology, 9 (5), 309-316. |
|
2000 Journal Article Ischemic acute renal failure: long-term histology of cell and matrix changes in the ratForbes, Josephine M., Hewitson, Timothy D., Becker, Gavin J. and Jones, Colin L. (2000). Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney International, 57 (6), 2375-2385. doi: 10.1046/j.1523-1755.2000.00097.x |
|
2000 Journal Article The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulationCooper, ME, Thallas, V, Forbes, J, Scalbert, E, Sastra, S, Darby, I and Soulis, T (2000). The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation. Diabetologia, 43 (5), 660-664. doi: 10.1007/s001250051355 |
|
2000 Journal Article Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosisCao, ZM, Kelly, DJ, Cox, A, Casley, D, Forbes, JM, Martinello, P, Dean, R, Gilbert, RE and Cooper, ME (2000). Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney International, 58 (6), 2437-2451. doi: 10.1046/j.1523-1755.2000.00427.x |
|
1999 Journal Article Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonistsForbes, Josephine M., Leaker, Brian, Hewitson, Tim D., Becker, Gavin J. and Jones, Colin L. (1999). Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists. Kidney International, 55 (1), 198-208. doi: 10.1046/j.1523-1755.1999.00253.x |
|
1997 Conference Publication Artificial activation of matrix metalloproteinases.Jones, CI, Forbes, JM, Walker, RG and Becker, GJ (1997). Artificial activation of matrix metalloproteinases.. BLACKWELL SCIENCE INC. |
|
1996 Conference Publication Activation of renal type IV collagenases.Jones, CL, Forbes, JM, Walker, RG and Becker, GJ (1996). Activation of renal type IV collagenases.. AMER SOC NEPHROLOGY. |
|
1995 Journal Article Tissue Inhibitor of the Metalloproteinases and Renal Extracellular-Matrix AccumulationJones, CL, Fecondo, J, Kelynack, K, Forbes, J, Walker, R and Becker, G (1995). Tissue Inhibitor of the Metalloproteinases and Renal Extracellular-Matrix Accumulation. Experimental Nephrology, 3 (2), 80-86. |
